Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder

Summary

This placebo-controlled study is designed to determine the efficacy, safety, and tolerability of vortioxetine in the treatment of adults with Major Depressive Disorder (MDD) that is comorbid with Social Anxiety Disorder (SAD). Half of the subjects will be randomized to receive vortioxetine and the other half will receive placebo.

Timeline

Start

2014-12

Primary completion

2016-11

Completion

2016-11

Drugs

Indications